Cargando…

Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups

OBJECTIVE: The objective of this study was to examine the effects of orlistat use on metabolic control and weight loss in diabetic and nondiabetic patients. METHODS: A total of 119 patients with body mass index≥40 kg/m(2) and receiving orlistat therapy, who applied to the Endocrinology polyclinic be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gunay, Yasemin Emur, Kişioğlu, Savaş Volkan, Karakullukçu, Serdar, Tufekcı, Damla, Demır, Ahmet Suat, Coskun, Hülya, Nuhoglu, Irfan, Kocak, Mustafa, Ersöz, Halil Önder
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Médica Brasileira 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352001/ https://www.ncbi.nlm.nih.gov/pubmed/37466599 http://dx.doi.org/10.1590/1806-9282.20230174

Ejemplares similares

Clinical research of insulin glargine U300 in type 1 diabetes mellitus patients with frequent hypoglycaemia: real-world experience
por: Kişioğlu, Savaş Volkan, et al.
Publicado: (2021)

Obesity management: Update on orlistat
por: Drew, Belinda S, et al.
Publicado: (2007)

Orlistat in the prevention of diabetes in the obese patient
por: Mancini, Marcio C, et al.
Publicado: (2008)

Macrocytic Anemia and Thrombocytopenia Induced by Orlistat
por: Palacios-Martinez, David, et al.
Publicado: (2013)

Acute oxalate nephropathy associated with orlistat
por: Humayun, Youshay, et al.
Publicado: (2016)

The effect of orlistat and weight loss diet on plasma ghrelin and obestatin
por: Pamuk, Baris, et al.
Publicado: (2018)

Evaluation of efficacy and safety of orlistat in obese patients
por: Jain, Suyog S., et al.
Publicado: (2011)

The Effect of Orlistat on Sterol Metabolism in Obese Patients
por: Kwon, Yu-Jin, et al.
Publicado: (2022)

High Sensitivity of Giardia duodenalis to Tetrahydrolipstatin (Orlistat) In Vitro
por: Hahn, Juliane, et al.
Publicado: (2013)

Orlistat-Induced Gut Microbiota Modification in Obese Mice
por: Ke, Jing, et al.
Publicado: (2020)

Clinical and economic considerations of antiobesity treatment: a review of orlistat
por: Zohrabian, Armineh
Publicado: (2010)

Taking Orlistat: Predicting Weight Loss over 6 Months
por: Hollywood, Amelia, et al.
Publicado: (2011)

Mechanism of Orlistat Hydrolysis by the Thioesterase of Human Fatty Acid Synthase
por: Fako, Valerie E., et al.
Publicado: (2014)

An Unexpected Result of Obesity Treatment: Orlistat-Related Acute Pancreatitis
por: Kose, Murat, et al.
Publicado: (2015)

The Application of Quantitative (1)H-NMR for the Determination of Orlistat in Tablets
por: Sun, Shanshan, et al.
Publicado: (2017)

Selection of orlistat as a potential inhibitor for lipase from Candida species
por: Khedidja, Benarous, et al.
Publicado: (2011)

Risk of colorectal cancer after initiation of orlistat: matched cohort study
por: Hong, Jin-Liern, et al.
Publicado: (2013)

Orlistat-loaded solid SNEDDS for the enhanced solubility, dissolution, and in vivo performance
por: Kim, Dae Hun, et al.
Publicado: (2018)

Comparision of Efficacy and Safety of Orlistat vs Placebo in Obese Patients in Pakistan
por: Syed, Asghar Hussain, et al.
Publicado: (2020)

The Use of Orlistat in an Adult with Lipoprotein Lipase Deficiency: A Case Report
por: Jarrett, Zachary S., et al.
Publicado: (2021)

Orlistat Induces Ferroptosis in Pancreatic Neuroendocrine Tumors by Inactivating the MAPK Pathway
por: Ye, Mujie, et al.
Publicado: (2023)

Pharmacological effect and mechanism of orlistat in anti-tumor therapy: A review
por: Hao, Xiaoqing, et al.
Publicado: (2023)

Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Overweight and Obese Patients
por: Halpern, Alfredo, et al.
Publicado: (2010)

Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose
por: Grudén, Stefan, et al.
Publicado: (2021)

Orlistat Resensitizes Sorafenib-Resistance in Hepatocellular Carcinoma Cells through Modulating Metabolism
por: Shueng, Pei-Wei, et al.
Publicado: (2022)

PPARγ as a sensor of lipase activity and a target for the lipase inhibitor orlistat
por: Martin, Harry, et al.
Publicado: (2013)

Postprandial Effect of Orlistat on the Peaking of Lipid Level After Sequential High Fat Meals
por: Gabriel, Frederick S., et al.
Publicado: (2012)

Acute Oxalate Nephropathy Associated with Orlistat: A Case Report with a Review of the Literature
por: Chaudhari, Dhara, et al.
Publicado: (2013)

Direct Measurement of Lipase Inhibition by Orlistat Using a Dissolution Linked In Vitro Assay
por: Lewis, Daniel R, et al.
Publicado: (2012)

Orlistat in polycystic ovarian syndrome reduces weight with improvement in lipid profile and pregnancy rates
por: Kumar, Pratap, et al.
Publicado: (2014)

Furosemide, orlistat and non-steroidal anti-inflammatory agents—too much for the kidneys to handle!
por: Korzets, Asher, et al.
Publicado: (2009)

Effect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients
por: Al-kuraishy, Hayder M., et al.
Publicado: (2016)

Crystal structure of pathogenic Staphylococcus aureus lipase complex with the anti-obesity drug orlistat
por: Kitadokoro, Kengo, et al.
Publicado: (2020)

Anti-Atherogenic Effects of Orlistat on Obesity-Induced Vascular Oxidative Stress Rat Model
por: Othman, Zaidatul Akmal, et al.
Publicado: (2021)

Influence of intense multidisciplinary follow-up and orlistat on weight reduction in a primary care setting
por: Feigenbaum, Amiel, et al.
Publicado: (2005)

Reversible Serum Carcinoembriogenic Antigen (CEA) Elevation Due to Orlistat Use: A Case Report
por: dos Santos Fernandes, Gustavo, et al.
Publicado: (2010)

Myelopoietic Efficacy of Orlistat in Murine Hosts Bearing T Cell Lymphoma: Implication in Macrophage Differentiation and Activation
por: Kant, Shiva, et al.
Publicado: (2013)

Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome
por: Salehpour, Saghar, et al.
Publicado: (2018)

Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity
por: Holmbäck, Ulf, et al.
Publicado: (2020)

Knockdown of PGM1 enhances anticancer effects of orlistat in gastric cancer under glucose deprivation
por: Cao, Bo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_98uhjnk3oo76t4ird57ob7io9p